Guideline for prophylactic anticoagulation

South African Medical Journal

Volumn 94, Issue 8 II, 2004, Pages 691-695

  Jacobson, Barry ^a  

^a Department of Haematology/NJH ^*  (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PROTAMINE SULFATE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; CARDIOLOGY; CLINICAL PRACTICE; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; DRUG MONITORING; EPIDURAL ANESTHESIA; GYNECOLOGY; HEMATOLOGY; HEMOSTASIS; HUMAN; INTENSIVE CARE; INTERNAL MEDICINE; INTERNATIONAL STANDARD UNIT; MEDICAL EXPERT; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NEUROLOGY; ORTHOPEDIC SURGERY; PATHOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; PULMONOLOGY; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; SPINAL ANESTHESIA; SURGICAL PATIENT; THROMBOPHILIA; THROMBOSIS; TREATMENT OUTCOME; VASCULAR SURGERY; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG MONITORING; EMBOLISM; FEMALE; HEMOSTASIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; POSTOPERATIVE CARE; PREGNANCY; PREOPERATIVE CARE; SOCIETIES, MEDICAL; SOUTH AFRICA; THROMBOSIS;

EID: 4444224843     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38: 2 suppl 5, 12-19.
2. Chai SJ, Macik BG. Improving the safety profile of warfarin. Semin Hematol 2002; 39 (3): 179-186.
3. Cohen A. Benefits of DVT prophylaxis in the nonsurgical patient. Semin Hematol 2001; 38: 2 suppl S, 531-538.
4. Dahl OE. Current controversies in DVT prophylaxis after orthopaedic surgery. Curr Opin Pulm Med 2002; 8: 5.
5. Hirsh J, Guyatt G, American College of Physicians. The 6th (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001; 119: 1 suppl, 1S-2S.
6. Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999; 159:137-141.
7. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 1998; 114: 5 suppl, 561S-578S.
8. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907. Erratum in: N Engl J Med 1999: 341: 298.
9. Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism, in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83: 14-19.
10. O'Shea SI, Ortel TL. Issues in the utilization of low molecular weight heparins. Semin Hematol 2002; 39: 172-178.
11. Palareti G. Bleeding complications of oral anticoagulant treatment. Lancet 1996; 348: 423-428.
12. Prandoni P. Heparins and venous thromboembolism: Current practice and future directions. Thromb Haemost 2001; 86: 488-498.
13. Pottier P, Planchon B, Truchaud F, Pistorius MA, Furic I, Grolleau JY. Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study. J Mal Vasc 2000; 25: 241-249.
14. Samama MM, Cohen AT, Damon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
15. Second Thromboembolic Risk Factors (THRIFT II) Consensus Group: Risk of prophylaxis for VTE in hospital patients. Phlebology 1998; 13: 87-97.